Terms: = Breast cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Staging
21 results:
1. Is There a Survival Difference Between Male and Female breast cancer Subtypes According to the Prognostic staging System? A Population-Based Cohort Study.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Apr; 90(4):788-799. PubMed ID: 37916470
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract] [Full Text] [Related]
3. Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the breast: A Retrospective Study of 46 Patients.
Luo H; Yi P; Wang W; Li K; Meng L; Li J; Zeng W; Tang M
Med Sci Monit; 2019 Nov; 25():8671-8682. PubMed ID: 31734687
[TBL] [Abstract] [Full Text] [Related]
4. Immunophenotyping of male breast cancer - Experience at a tertiary care centre.
Pasricha S; Kamboj M; Tanwar P; Gupta G; Panigrahi M; Sharma A; Durga G; Mehta A
Indian J Pathol Microbiol; 2019; 62(2):226-231. PubMed ID: 30971545
[TBL] [Abstract] [Full Text] [Related]
5. Protein expressions of AIB1, p53 and bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis.
Liang M; Zhao J
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5134-5139. PubMed ID: 30178833
[TBL] [Abstract] [Full Text] [Related]
6. Magnetic resonance (MR) features in triple negative breast cancer (TNBC) vs receptor positive cancer (nTNBC).
Angelini G; Marini C; Iacconi C; Mazzotta D; Moretti M; Picano E; Morganti R
Clin Imaging; 2018; 49():12-16. PubMed ID: 29120811
[TBL] [Abstract] [Full Text] [Related]
7. Effects of cyclin D1 gene silencing on cell proliferation, cell cycle, and apoptosis of hepatocellular carcinoma cells.
Chen J; Li X; Cheng Q; Ning D; Ma J; Zhang ZP; Chen XP; Jiang L
J Cell Biochem; 2018 Feb; 119(2):2368-2380. PubMed ID: 28885717
[TBL] [Abstract] [Full Text] [Related]
8. Outcomes After Mastectomy and Lumpectomy in Elderly Patients with Early-Stage breast cancer.
Mogal HD; Clark C; Dodson R; Fino NF; Howard-McNatt M
Ann Surg Oncol; 2017 Jan; 24(1):100-107. PubMed ID: 27654110
[TBL] [Abstract] [Full Text] [Related]
9. Classical Hodgkin Lymphoma Arising Adjacent to a breast Implant.
Ryan C; Ged Y; Quinn F; Walker J; Kennedy J; Gillham C; Pittaluga S; McDermott R; Vandenberghe E; Grant C; Flavin R
Int J Surg Pathol; 2016 Aug; 24(5):448-55. PubMed ID: 26888955
[TBL] [Abstract] [Full Text] [Related]
10. Differential roles of bcl2L12 and its short variant in breast cancer lymph node metastasis.
Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM
Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034
[TBL] [Abstract] [Full Text] [Related]
11. [Primary lymphoma of breast: a clinicopathologic and prognostic study of 40 cases].
Yang H; Lang RG; Liu FF; Wang XF; Jin ZJ; Lü AJ; Wang Y; Fu XL; Fu L
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):79-84. PubMed ID: 21426801
[TBL] [Abstract] [Full Text] [Related]
12. [Primary lymphoma of breast: a clinicopathologic, immunophenotypic and prognostic study of 21 cases].
Wang XQ; Zhang LX; Bi CF; Luo TY; Lin L; Min M; Zhao Y; He GX; Feng J; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):302-7. PubMed ID: 20654152
[TBL] [Abstract] [Full Text] [Related]
13. Predictive markers of response to neoadjuvant chemotherapy in breast cancer.
Tewari M; Krishnamurthy A; Shukla HS
Surg Oncol; 2008 Dec; 17(4):301-11. PubMed ID: 18467090
[TBL] [Abstract] [Full Text] [Related]
14. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
Biglia N; Mariani L; Sgro L; Mininanni P; Moggio G; Sismondi P
Endocr Relat Cancer; 2007 Sep; 14(3):549-67. PubMed ID: 17914088
[TBL] [Abstract] [Full Text] [Related]
15. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging.
Ciatto S; Brancato B; Risso G; Ambrogetti D; Bulgaresi P; Maddau C; Turco P; Houssami N
Breast Cancer Res Treat; 2007 May; 103(1):85-91. PubMed ID: 17033920
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Mavroudis D; Kouroussis C; Mavroudi C; Perraki M; Sivridis E; Georgoulias V
Int J Cancer; 2004 Feb; 108(4):620-7. PubMed ID: 14696130
[TBL] [Abstract] [Full Text] [Related]
17. Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study.
Briasoulis E; Agnantis NJ; Zagorianakou P; Kamina S; Gorezi M; Pavlidis N; Bai M
J Exp Clin Cancer Res; 2001 Sep; 20(3):341-4. PubMed ID: 11718212
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.
Fitzgibbons PL; Page DL; Weaver D; Thor AD; Allred DC; Clark GM; Ruby SG; O'Malley F; Simpson JF; Connolly JL; Hayes DF; Edge SB; Lichter A; Schnitt SJ
Arch Pathol Lab Med; 2000 Jul; 124(7):966-78. PubMed ID: 10888772
[TBL] [Abstract] [Full Text] [Related]
19. Comparative immunohistochemical and molecular analysis of uterine and extrauterine leiomyosarcomas.
Rao UN; Finkelstein SD; Jones MW
Mod Pathol; 1999 Nov; 12(11):1001-9. PubMed ID: 10574596
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of bcl-2 expression in invasive breast cancer.
Hellemans P; van Dam PA; Weyler J; van Oosterom AT; Buytaert P; Van Marck E
Br J Cancer; 1995 Aug; 72(2):354-60. PubMed ID: 7640218
[TBL] [Abstract] [Full Text] [Related]
[Next]
